RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$73.71
−1.22%Forward multiples
Based on analyst estimates
- P/E forward
- 107.16x
- P/E 2026E
- 144.01x
- P/E 2027E
- 83.53x
- P/E 2028E
- 62.24x
- P/S forward
- 2.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.29x
- Price / sales
- 2.56x
- Price / cash flow
- 18.30x
Enterprise value
- Enterprise value
- $7.6B
- EV / sales
- 3.33x
- EV / EBITDA
- 22.40x
- EV / EBIT
- 83.17x
- Market cap
- $5.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026